The clinical trial about the coronary plaque change by Rosuvastatin in ACS patients

The clinical trial about the coronary plaque change by Rosuvastatin in ACS patients - The clinical trial about the coronary plaque change by Rosuvastatin in ACS patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004302

Enrollment

Registered

2010-10-15

Start date

2010-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Coronary Syndrome

Interventions

Rosuvastatin group coronary plaque change after 2weeks with Rosuvastatin Control group coronary plaque change after 2weeks without Rosuvastatin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Acute Coronary Syndrome

Exclusion criteria

Exclusion criteria: cardiac shock allergy to Rosuvastation

Design outcomes

Primary

Measure	Time frame
Observation of coronary plaque change in 2 weeks after taking the Rosuvastatin	—

Countries

Japan

Contacts

Public ContactYoshio Taketani

Tokushima University Hospital department of cardiology

088-633-7851

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026